| First Author | Brial F | Year | 2015 |
| Journal | Diabetes | Volume | 64 |
| Issue | 9 | Pages | 3314-20 |
| PubMed ID | 25979074 | Mgi Jnum | J:247237 |
| Mgi Id | MGI:5924069 | Doi | 10.2337/db15-0124 |
| Citation | Brial F, et al. (2015) Ghrelin Inhibition Restores Glucose Homeostasis in Hepatocyte Nuclear Factor-1alpha (MODY3)-Deficient Mice. Diabetes 64(9):3314-20 |
| abstractText | Hepatocyte nuclear factor-1alpha (HNF1alpha) is a transcription factor expressed in tissues of endoderm origin. Mutations in HNF1A are associated with maturity-onset diabetes of the young 3 (MODY3). Mice deficient for Hnf1alpha are hyperglycemic, with their pancreatic beta-cells being defective in glucose-sensing insulin secretion. The specific mechanisms involved in this defect are unclear. Gut hormones control glucose homeostasis. Our objective was to explore whether changes in these hormones play a role in glucose homeostasis in the absence of Hnf1alpha. An increase in ghrelin gene transcript and a decrease in glucose-dependent insulinotropic polypeptide (GIP) gene transcripts were observed in the gut of Hnf1alpha-null mice. These changes correlated with an increase of ghrelin and a decrease of GIP-labeled cells. Ghrelin serological levels were significantly induced in Hnf1alpha-null mice. Paradoxically, GIP levels were also induced in these mice. Treatment of Hnf1alpha-null mice with a ghrelin antagonist led to a recovery of the diabetic symptoms. We conclude that upregulation of ghrelin in the absence of Hnf1alpha impairs insulin secretion and can be reversed by pharmacological inhibition of ghrelin/GHS-R interaction. These observations open up on future strategies to counteract ghrelin action in a program that could become beneficial in controlling non-insulin-dependent diabetes. |
